Company / Interest Expense
Zimmer Biomet Interest Expense History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$325.3M
FY2019
5-year range
-
FY2016-FY2019
Trend
+8.4%
vs FY2018
Sector context
#45 of 44
Health Care
What the data says
Among 44 Health Care companies, Zimmer Biomet is in the top -2% for interest expense. Improved from $328M to -$325M over the past 2 years.
Based on SEC 10-K filings.
-$325M in FY2019.
Improved from $328M to -$325M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 44This company -$325.3M Sector average $316.9M
▼
-202.6% below sector average
Key checks
Key Insights
- In FY2019, interest expense increased 8.4% year-over-year.
- Ranks #45 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$325.3M | +8.4% |
| FY2018 | -$355.0M | -208.4% |
| FY2017 | $327.5M | +419.0% |
| FY2016 | $63.1M | -78.0% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026